Century Therapeutics, Inc. (IPSC)
1.65
+0.02
(+1.23%)
USD |
NASDAQ |
Nov 13, 16:00
1.655
0.00 (0.00%)
After-Hours: 19:59
Century Therapeutics Price to Book Value : 1.424 for Nov. 13, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 1.424 |
| November 12, 2026 | 1.407 |
| November 11, 2026 | 1.502 |
| November 10, 2026 | 1.450 |
| November 09, 2026 | 1.562 |
| November 06, 2026 | 1.450 |
| November 05, 2026 | 1.303 |
| November 04, 2026 | 1.442 |
| November 03, 2026 | 1.312 |
| November 02, 2026 | 1.278 |
| October 30, 2026 | 1.269 |
| October 29, 2026 | 1.260 |
| October 28, 2026 | 1.295 |
| October 27, 2026 | 1.252 |
| October 26, 2026 | 1.226 |
| October 23, 2026 | 1.260 |
| October 22, 2026 | 1.364 |
| October 21, 2026 | 1.390 |
| October 20, 2026 | 1.416 |
| October 19, 2026 | 1.269 |
| October 16, 2026 | 1.183 |
| October 15, 2026 | 1.295 |
| October 14, 2026 | 1.191 |
| October 13, 2026 | 1.191 |
| October 12, 2026 | 1.243 |
| Date | Value |
|---|---|
| October 09, 2026 | 1.269 |
| October 08, 2026 | 1.260 |
| October 07, 2026 | 1.105 |
| October 06, 2026 | 1.139 |
| October 05, 2026 | 1.278 |
| October 02, 2026 | 1.321 |
| October 01, 2026 | 1.390 |
| September 30, 2026 | 1.476 |
| September 29, 2026 | 1.282 |
| September 28, 2026 | 1.298 |
| September 25, 2026 | 1.298 |
| September 24, 2026 | 1.313 |
| September 23, 2026 | 1.368 |
| September 22, 2026 | 1.469 |
| September 21, 2026 | 1.438 |
| September 18, 2026 | 1.445 |
| September 17, 2026 | 1.461 |
| September 16, 2026 | 1.445 |
| September 15, 2026 | 1.539 |
| September 14, 2026 | 1.554 |
| September 11, 2026 | 1.508 |
| September 10, 2026 | 1.508 |
| September 09, 2026 | 1.577 |
| September 08, 2026 | 1.608 |
| September 04, 2026 | 1.640 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Tenax Therapeutics, Inc. | 0.6789 |
| Exicure, Inc. | 7.046 |
| Absci Corp. | 6.661 |
| Celularity, Inc. | -- |
| Cardio Diagnostics Holdings, Inc. | 0.9782 |
Price to Book Value Related Metrics
| PEG Ratio | -0.0278 |
| Price | 1.65 |
| Earnings Yield | -37.12% |
| Market Cap | 297.90M |
| PEGY Ratio | -0.0278 |